{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "9627106",
  "DateCompleted": {
    "Year": "1998",
    "Month": "06",
    "Day": "24"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "02",
    "Day": "27"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0024-3205",
      "JournalIssue": {
        "Volume": "62",
        "Issue": "22",
        "PubDate": {
          "Year": "1998"
        }
      },
      "Title": "Life sciences",
      "ISOAbbreviation": "Life Sci"
    },
    "ArticleTitle": "Inhibition of nitric oxide synthase results in a suppression of interleukin-1beta-induced fever in rats.",
    "Pagination": {
      "MedlinePgn": "PL 345-50"
    },
    "Abstract": {
      "AbstractText": [
        "Pro-inflammatory cytokines such as interleukin-1beta (IL-1beta) induce nitric oxide synthase. The purpose of this study was to investigate the role of endogenous nitric oxide in IL-1beta-induced fever in rats. At a dose of 2.5 microg per animal intraperitoneal (i.p.) injections of rat recombinant IL-1beta evoked a febrile response with a duration of 8 hours. Simultaneous i.p. injection of 50 mg/kg N-nitro-L-arginine methyl ester hydrochloride (L-NAME) resulted in a complete suppression of IL-1beta-induced fever in rats. I.p. injection of 50 mg/kg L-NAME alone had no apparent influence on body core temperature. Endogenous formation of IL-6 in response to IL-1beta was not suppressed but rather enhanced by treatment with L-NAME during the early stage of IL-1beta-induced fever. This result indicates that activation of nitric oxide synthase and thereby endogenous NO-formation is essential for the generation of an IL-1beta-induced febrile response in rats and that the suppression of IL-1beta-induced fever by treatment with L-NAME seems not to be caused by an inhibition of IL-6 production."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institut f\u00fcr Normale und Pathologische Physiologie, Marburg, Germany."
          }
        ],
        "LastName": "Roth",
        "ForeName": "J",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "St\u00f6rr",
        "ForeName": "B",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Voigt",
        "ForeName": "K",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Zeisberger",
        "ForeName": "E",
        "Initials": "E"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Life Sci",
    "NlmUniqueID": "0375521",
    "ISSNLinking": "0024-3205"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Enzyme Inhibitors"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Interleukin-1"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Interleukin-6"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Recombinant Proteins"
    },
    {
      "RegistryNumber": "31C4KY9ESH",
      "NameOfSubstance": "Nitric Oxide"
    },
    {
      "RegistryNumber": "EC 1.14.13.39",
      "NameOfSubstance": "Nitric Oxide Synthase"
    },
    {
      "RegistryNumber": "V55S2QJN2X",
      "NameOfSubstance": "NG-Nitroarginine Methyl Ester"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Body Temperature"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Enzyme Inhibitors"
    },
    {
      "QualifierName": [
        "chemically induced",
        "metabolism",
        "prevention & control"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [
        "toxicity"
      ],
      "DescriptorName": "Interleukin-1"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Interleukin-6"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "NG-Nitroarginine Methyl Ester"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Nitric Oxide"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors"
      ],
      "DescriptorName": "Nitric Oxide Synthase"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats, Wistar"
    },
    {
      "QualifierName": [
        "toxicity"
      ],
      "DescriptorName": "Recombinant Proteins"
    }
  ]
}